Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Tobramycin (inhalation use)

EU orphan designation number: EU/3/09/613
Active ingredient: Tobramycin (inhalation use)
Indication: Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
Sponsor: PARI Pharma GmbH
Moosstrasse 3, D-82319 Starnberg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Orphan designation EMEA/OD/094/08 (2009)1522 of 27/02/2009
05/11/2010 Change of address of sponsor EMA/367444/2010
30/05/2011 Change of address of sponsor EMEA/OD/094/08
19/06/2014 Removal of orphan designation from Community Register